State of genomics and epigenomics research in the perspective of HIV cure

Current Opinion in HIV and AIDS

Volumn 8, Issue 3, 2013, Pages 176-181

  Ciuffi, Angela ^a   Telenti, Amalio ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

antisense transcription; deep sequencing; epigenetic regulation; integration

Indexed keywords

MICRORNA; PROTEOME; SMALL INTERFERING RNA; TRANSCRIPTOME;

ALTERNATIVE RNA SPLICING; CD4+ T LYMPHOCYTE; CELL HETEROGENEITY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; DISEASE COURSE; DNA METHYLATION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE REPLICATION; GENOMICS; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROVIRUS; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION ELONGATION; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION;

BIOMEDICAL RESEARCH; EPIGENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, BIOLOGICAL; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 84876414537     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32835f7340     Document Type: Review

References (46)

1. International AIDS Society Scientific Working Group on HIV Cure. Deeks SG, Autran B, Berkhout B, et al. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol 2012; 12:607-614.
2. Pace MJ, Agosto L, Graf EH, O'Doherty U. HIV reservoirs and latency models. Virology 2011; 411:344-354.
3. Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med 2011; 1:a007096.
4. Hakre S, Chavez L, Shirakawa K, Verdin E. HIV latency: experimental systems and molecular models. FEMS Microbiol Rev 2012; 36:706-716.
5. Yang HC, Xing S, Shan L, et al. Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation. J Clin Invest 2009; 119:3473-3486.
6. Planelles V, Wolschendorf F, Kutsch O. Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs. Curr HIV Res 2011; 9:568-578.
7. Gallastegui E, Marshall B, Vidal D, et al. Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1. J Virol 2012; 86:3795-3808.
8. + T cell model without inducing global T cell activation. J Antimicrob Chemother 2012; 67:398-403.
9. Smith MZ, Wightman F, Lewin SR. HIV reservoirs and strategies for eradication. Curr HIV/AIDS Rep 2012; 9:5-15.
10. Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 2012; 487:482-485.
11. Bushman FD, Nabel GJ, Swanstrom R. HIV-from biology to prevention and treatment. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2012.
12. Mehla R, Ayyavoo V. Gene array studies in HIV-1 infection. Curr HIV/AIDS Rep 2012; 9:34-43.
13. Craigie R, Bushman FD. HIV DNA integration. Cold Spring Harb Perspect Med 2012; 2:a006890.
14. Imbeault M, Giguere K, Ouellet M, Tremblay MJ. Exon level transcriptomic profiling of HIV-1-infected CD4(+) T cells reveals virus-induced genes and host environment favorable for viral replication. PLoS Pathog 2012; 8:e1002861.
15. Lefebvre G, Desfarges S, Uyttebroeck F, et al. Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell. J Virol 2011; 85:6205-6211.
16. Laverdure S, Gross A, Arpin-Andre C, et al. HIV-1 antisense transcription is preferentially activated in primary monocyte-derived cells. J Virol 2012; 86:13785-13789.
17. Kobayashi-Ishihara M, Yamagishi M, Hara T, et al. HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology 2012; 9:38.
18. Schopman NC, Willemsen M, Liu YP, et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 2012; 40:414-427.
19. Ocwieja KE, Sherrill-Mix S, Mukherjee R, et al. Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res 2012; 40:10345-10355.
20. Mohammadi P, Desfarges S, Bartha I, et al. 24 h in the life of HIV-1 in a T cell line. PLoS Pathog 2013; 9:e1003161.
21. Desfarges S, Ciuffi A. Retroviral integration site selection. Viruses 2010; 2:111-130.
22. + T cells can produce HIV Gagwithout spreading infection in a model of HIV latency. PloS Pathog 2012; 8:e1002818.
23. Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 2003; 22:1868-1877.
24. Lewinski MK, Bisgrove D, Shinn P, et al. Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 2005; 79:6610-6619.
25. + T cells infected in culture. AIDS 2009; 23:1461-1471.
26. + T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J Virol 2004; 78:6122-6133.
27. Han Y, Lin YB, An W, et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 2008; 4:134-146.
28. Shan L, Yang HC, Rabi SA, et al. Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model. J Virol 2011; 85:5384-5393.
29. Citri A, Pang ZP, Sudhof TC, et al. Comprehensive qPCR profiling of gene expression in single neuronal cells. Nat Protoc 2012; 7:118-127.
30. Bock C, Kiskinis E, Verstappen G, et al. Reference maps ofhumanES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011; 144:439-452.
31. Miller-Jensen K, Dey SS, Pham N, et al. Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-kappaB mediated viral gene expression. Integr Biol 2012; 4:661-671.
32. + T-cells from HIV-1-infected individuals. PLoS Pathog 2010; 6:e1000781.
33. Rotger M, Dalmau J, Rauch A, et al. Comparative transcriptome analysis of extreme phenotypes of human HIV-1 infection and sooty mangabey and rhesus macaque models of SIV infection. J Clin Invest 2011; 121:2391-2400.
34. Vigneault F, Woods M, Buzon MJ, et al. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol 2011; 85:3015-3019.
35. Grigoryev YA, Kurian SM, Nakorchevskiy AA, et al. Genome-wide analysis of immune activation in human T and B cells reveals distinct classes of alternatively spliced genes. PLoS One 2009; 4:e7906.
36. Butte MJ, Lee SJ, Jesneck J, et al. CD28 costimulation regulates genome-wide effects on alternative splicing. PLoS One 2012; 7:e40032.
37. Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet 2011; 12:715-729.
38. Colin L, Van Lint C. Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 2009; 6:111.
39. Tyagi M, Karn J. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J 2007; 26:4985-4995.
40. + T cells. J Virol 2013; 87:1211-1220.
41. Verdin E, Paras P Jr, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 1993; 12:3249-3259.
42. Rafati H, Parra M, Hakre S, et al. Repressive LTR nucleosome positioning by the BAF complex is required for HIV latency. PLoS Biol 2011; 9:e1001206.
43. Easley R, Carpio L, Dannenberg L, et al. Transcription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcription. Virology 2010; 405:322-333.
44. + cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J Virol 2010; 84:6425-6437.
45. Blazkova J, Trejbalova K, Gondois-Rey F, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog 2009; 5:e1000554.
46. Kauder SE, Bosque A, Lindqvist A, et al. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 2009; 5:e1000495.